Renexxion Alternatives & Competitors

12 companies similar to Renexxion

Entero Therapeutics (Nasdaq: ENTO)

A biopharma company focused on the development of targeted, non-systemic therapies for gas...

12 Post-IPO Equity

Boca Raton, United States

Biotechnology Health Care +1

Structure Therapeutics

Developing accessible oral small molecule therapies for the treatment of chronic diseases...

219 IPO $1.79B

South San Francisco, Unit...

Biotechnology Health Care +1

Biosight Ltd.

Developing innovative pharmaceuticals for hematological malignancies and disorders

3 Series C $59.00M

Lod, Israel

Biotechnology Health Care +2

Zai Lab

Delivering innovative, transformational outcomes to patients around the world

529 IPO $2.59B

China

Biotechnology Health Care +1

Track all Renexxion competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Verdiva Bio

Transforming lives by accelerating innovation in cardiometabolic health

78 Series A $411.00M

London, United Kingdom

Biotechnology Pharmaceutical

Entera Bio Ltd.

Developing innovative oral delivery of therapeutic proteins.

19 Post-IPO Equity $30.42M

Biopharma Biotechnology +1

Agennix

Crafting novel therapies to enhance the length and quality of life for seriously ill patie...

Venture round $111.00M

Biopharma Biotechnology +2

Tvardi Therapeutics

Breakthrough Medicines for Cancer, Chronic Inflammation & Fibrosis

18 Series B $81.42M

Houston, United States

Biotechnology Health Care +1

Helicore Biopharma

Long-Acting Medicines to Transform Metabolic Health

7 Series A $65.00M

San Mateo, United States

Biotechnology Pharmaceutical

Trevi Therapeutics, Inc.

Clinical-stage biopharmaceutical company

34 Post-IPO Equity $156.53M

New Haven, United States

Biotechnology Health Care +1

Alkeus Pharmaceuticals, Inc.

Transformation in Sight

58 Series B $150.10M

Biotechnology Medical Devices +1

Rivus Pharmaceuticals

Developing new oral medicines to advance cardiometabolic health

29 Series B $167.00M

Charlottesville, United S...

Biotechnology Health Care +1

Frequently Asked Questions

Companies similar to Renexxion include Entero Therapeutics (Nasdaq: ENTO), Structure Therapeutics, Biosight Ltd., Zai Lab, Verdiva Bio. They work in Biotechnology and Pharmaceutical.

Bounce Watch lists 12 companies that share Renexxion's industries and are closest to it in business tags, services, target customers, business model and size.

Renexxion is a biotechnology and pharmaceutical startup founded in 2014 that is working to address the unmet medical needs of patients struggling with functional gastrointestinal disorders. The company is focused on the development of Naronapride, an advanced-stage, Phase-3 ready, oral gastro-prokinetic drug within the...

Don't just read about them. Follow them.

BounceWatch watches Renexxion and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Renexxion Profile Entero Therapeutics (Nasdaq: ENTO) Alternatives Structure Therapeutics Alternatives Biosight Ltd. Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Renexxion on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.